[SGLT2 Inhibitors: Rationale and Perspectives of Use in Heart Failure].

Kobalava, Z D; Lazarev, P V; Villevalde, S V

Kobalava, Z D; Lazarev, P V; Villevalde, S V.

Affiliation

Kobalava ZD; Federal State Autonomous Educational Institution of Higher Education, "Peoples' Friendship University of Russia".
Lazarev PV; Federal State Autonomous Educational Institution of Higher Education, "Peoples' Friendship University of Russia".
Villevalde SV; Federal State Autonomous Educational Institution of Higher Education, "Peoples' Friendship University of Russia".

Kardiologiia ; (2): 42-54, 2018 Feb.

Article de Ru | MEDLINE | ID: mdl-29466200

Sujet(s)
Mots clés

SGLT2 inhibitors; diabetes; glyflozines; heart failure

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Défaillance cardiaque Limites: Humans Langue: Ru Journal: Kardiologiia Année: 2018 Type de document: Article Pays de publication: Russie

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links